Horizon Kinetics Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Horizon Kinetics Asset Management's LLY Position: Q2 2026 in Review
Horizon Kinetics Asset Management reduced its Eli Lilly (LLY) stake by 3.6% in Q2 2026, selling an estimated $144K and leaving 3,824 shares worth $4.59M. The position accounts for 0.05% of the portfolio, ranked #73.
Horizon Kinetics Asset Management first reported a position in LLY in Q1 2019 and has held it in 29 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Horizon Kinetics Asset Management held 3,824 shares of Eli Lilly worth $4.59M as of Q2 2026.
- Horizon Kinetics Asset Management sold 141 Eli Lilly shares in Q2 2026, an estimated $144K.
- Eli Lilly made up 0.05% of Horizon Kinetics Asset Management's portfolio in Q2 2026, its #73 holding.
- Horizon Kinetics Asset Management first reported a position in Eli Lilly in Q1 2019 and has held it in 29 quarters since.
- 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Horizon Kinetics Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.